The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients
Condition(s):Hepatitis B; InterferonLast Updated:October 14, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Hepatitis B; InterferonLast Updated:October 14, 2020Completed
Condition(s):Interferon-A-2B; Relapse; Prevention; Hematopietic Stem Cell TransplantationLast Updated:September 23, 2020Withdrawn
Condition(s):LeukemiaLast Updated:June 7, 2018Recruiting
Condition(s):Chronic Hepatitis BLast Updated:May 2, 2012Unknown status
Condition(s):Hematological Neoplasms; RecurrenceLast Updated:April 21, 2020Recruiting
Condition(s):HealthyLast Updated:October 26, 2010Completed
Condition(s):Essential ThrombocytopeniaLast Updated:January 13, 2020Recruiting
Condition(s):Chronic Hepatitis BLast Updated:July 23, 2019Completed
Condition(s):HIV InfectionLast Updated:April 23, 2019Completed
Condition(s):LeukemiaLast Updated:September 29, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.